Cytokinetics
CYTK
CYTK
148 hedge funds and large institutions have $513M invested in Cytokinetics in 2019 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 54 increasing their positions, 37 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2% more capital invested
Capital invested by funds: $502M → $513M (+$11.3M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.48% less ownership
Funds ownership: 77.37% → 76.89% (-0.48%)
Holders
148
Holding in Top 10
3
Calls
$3.93M
Puts
$381K
Top Buyers
| 1 | +$10.3M | |
| 2 | +$6.06M | |
| 3 | +$3.98M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$2.56M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$2.4M |
Top Sellers
| 1 | -$11.5M | |
| 2 | -$8.6M | |
| 3 | -$3.39M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$2.85M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.97M |